Quest Diagnostics (DGX) FCF Payout Ratio Growth (1y) (2010 - 2026)
Quest Diagnostics (DGX) FCF Payout Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | -28.74% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 6.48% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | -45.25% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | - |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 1.32% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 253.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32% |
| Mar 31, 2026 | 25.84% |
| Dec 31, 2025 | 19.01% |
| Sep 30, 2025 | -36.78% |
| Jun 30, 2025 | -34.14% |
| Mar 31, 2025 | -73.01% |
| Dec 31, 2024 | 40.10% |
| Sep 30, 2024 | -57.16% |
| Jun 30, 2024 | 33.21% |
| Mar 31, 2024 | 170.46% |
| Dec 31, 2023 | -56.16% |
| Sep 30, 2023 | 286.12% |
| Jun 30, 2023 | -1.66% |
| Mar 31, 2023 | -1,363.64% |
| Dec 31, 2022 | 75.53% |
| Sep 30, 2022 | 26.15% |
| Jun 30, 2022 | 11.07% |
| Mar 31, 2022 | 52.61% |
| Dec 31, 2021 | 15.46% |
| Sep 30, 2021 | 63.35% |